Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
riviciclib (1 trial)
Carcinoma (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Trials (1 total)
Trial APIs (1 total)